These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16911506)

  • 21. Unrelated peripheral blood stem cell transplantation with 'megadoses' of purified CD34+ cells in three children with refractory severe aplastic anemia.
    Schwinger W; Urban C; Lackner H; Kerbl R; Benesch M; Dornbusch HJ; Sovinz P; Schauenstein K; Schumm M; Handgretinger R
    Bone Marrow Transplant; 2000 Mar; 25(5):513-7. PubMed ID: 10713628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of donor lymphocyte infusions in thalassemia patients at imminent risk of graft rejection following stem cell transplantation.
    Karasu GT; Yesilipek MA; Karauzum SB; Uygun V; Manguoglu E; Kupesiz A; Hazar V
    Pediatr Blood Cancer; 2012 Mar; 58(3):453-8. PubMed ID: 21990066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monitoring and treatment strategy for chronic renal allograft rejection].
    Kyo M; Namba Y; Takahara S
    Nihon Jinzo Gakkai Shi; 2008; 50(7):894-8. PubMed ID: 19069146
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk assessment in haematopoietic stem cell transplantation: impact of donor-recipient sex combination in allogeneic transplantation.
    Gahrton G
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):219-29. PubMed ID: 17448958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of early rehabilitation on the duration of hospitalization in patients after allogeneic hematopoietic stem cell transplantation.
    Inoue J; Ono R; Okamura A; Matsui T; Takekoshi H; Miwa M; Kurosaka M; Saura R; Shimada T
    Transplant Proc; 2010 Sep; 42(7):2740-4. PubMed ID: 20832579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia.
    George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Pediatr Transplant; 2008 Feb; 12(1):14-9. PubMed ID: 18086256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation.
    Wolff SN
    Bone Marrow Transplant; 2002 Apr; 29(7):545-52. PubMed ID: 11979301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imminent allograft rejection prevented by donor lymphocyte transfusions: report of two pediatric cases.
    Saarinen-Pihkala UM; Taskinen M; Vettenranta K; Hovi L
    Bone Marrow Transplant; 2003 May; 31(9):833-6. PubMed ID: 12732894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Durable remission following a third allogeneic stem cell transplantation in a patient with repeatedly relapsing SAA. The importance of stroma cells for sustained engraftment?
    Weber-Mzell D; Urban C; Benesch M; Rojacher T; Zois B; Höfler G; Schwinger W
    Pediatr Transplant; 2007 May; 11(3):332-5. PubMed ID: 17430493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equations to estimate GFR using serum cystatin C in kidney transplant recipients.
    Pöge U; Gerhardt T; Woitas RP
    Am J Kidney Dis; 2008 Aug; 52(2):383-4. PubMed ID: 18640490
    [No Abstract]   [Full Text] [Related]  

  • 33. Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation.
    McCune JS; Gooley T; Gibbs JP; Sanders JE; Petersdorf EW; Appelbaum FR; Anasetti C; Risler L; Sultan D; Slattery JT
    Bone Marrow Transplant; 2002 Aug; 30(3):167-73. PubMed ID: 12189535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Allogeneic hematopoietic stem cell transplantation for 16 patients with aplastic anemia].
    Zhai WH; Wang M; Zhou Z; Zhai WJ; Zhang RL; Wang H; Song AX; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):78-82. PubMed ID: 17650665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation.
    Fernandes J; Rocha V; Robin M; de Latour RP; Traineau R; Devergie A; Ribaud P; Réa D; Larghero J; Gluckman E; Socié G
    Br J Haematol; 2007 May; 137(3):248-51. PubMed ID: 17408466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
    Urban C; Benesch M; Sykora KW; Schwinger W; Lackner H
    Bone Marrow Transplant; 2005 Mar; 35(6):591-4. PubMed ID: 15665850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Roles of clinical laboratory monitoring in bone marrow and peripheral blood stem cell transplantation].
    Hino M; Yamane T; Ohta K; Nakaie K; Kubota H; Fujino K; Takubo T; Tatsumi N
    Rinsho Byori; 2001 Jul; 49(7):657-61. PubMed ID: 11519125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.